Why Top Investors Are Buying Bristol-Myers Squibb Co (BMY)
Bristol-Myers Squibb(US:BMY) Acquirersmultiple·2025-10-13 22:27According to their latest 13F filings, institutional investors made a series of notable moves in Bristol-Myers Squibb (BMY), reflecting growing confidence in the pharmaceutical giant’s pipeline strength, consistent cash flows, and attractive valuation amid ongoing healthcare sector volatility. Several top asset managers added meaningfully to their positions during the most recent quarter.Let’s examine some of the most notable changes:Pzena Investment Management LLC (Rich Pzena)Shares: 14,843,475Change: +1,3 ...